Table 1.
Characteristics of the study population.
| Characteristics of the study populationa | Recurrence (N = 19) | No recurrence (N = 49) | p value |
|---|---|---|---|
| Male, N (%) | 9 (47) | 21 (43) | 0.61 |
| Age (years), median (IQR) | 62 (55, 72) | 63 (51, 74) | 0.73 |
| BMI (kg/m2), median (IQR) | 27.8 (25, 30.8) | 26.8 (23.6, 30.9) | 0.32 |
| IFG or diabetes, N (%) | 2 (11) | 9 (18) | 0.44 |
| WBCb(×103/mm3), median (IQR) | 10.3 (7.1, 12.5) | 11.30 (6.6, 12.8) | 0.95 |
| Creatinineb (mg/dL), median (IQR) | 0.90 (0.80, 1.01) | 0.97 (0.78, 1.38) | 0.43 |
| Albumin (g/dL), median (IQR) | 3.45 (2.95, 4.40) | 3.50 (3.10, 4.10) | 0.92 |
| Antibiotic prescribed within 8 weeks prior to CDI, N (%) | 18 (95) | 35 (71) | 0.038 |
| Antibiotic prescribed within 4 weeks prior to CDI, N (%) | 17 (89) | 25 (51) | 0.003 |
| Prescribed proton pump inhibitor, N (%) | 2 (11) | 10 (20) | 0.35 |
| Prescribed H2 blocker, N (%) | 1 (5.3) | 4 (8.2) | 0.69 |
| Admitted to hospital, N (%) | 12 (63) | 25 (51) | 0.38 |
| Days of hospitalization, median (IQR) | 3.5 (3.50, 5.25) | 4.0 (3.0, 4.0) | 0.59 |
| Initial treatment with metronidazole, N (%) | 16 (84) | 41 (84) | 0.50 |
| Initial treatment with vancomycin, N (%) | 2 (11) | 8 (16) | 0.33 |
| Initial treatment with metronidazole and vancomycin, N (%) | 1 (5.3) | 0 (0) | 0.054 |
aMissing values: WBC = 14, creatinine = 12, and albumin = 15.
bThe highest value if more than one value present.